LYPRO BIOSCIENCES, INC.

Company Information
Address 2929 7th Street
Suite 120
Berkeley, CA, 94710


Information

DUNS: 170950484

# of Employees: 4


Ownership Information

Hubzone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. NanoDisk-Amphotericin B therapy for aspergillosis

    Amount: $1,471,850.00

    DESCRIPTION (provided by applicant): Aspergillus fumigatus is an opportunistic pathogenic fungus that predominantly infects immunocompromised patients. It is the most common cause of infectious pneumo ...

    SBIRPhase II2010Department of Health and Human Services
  2. Nanobiotechnology for the Treatment of Mantle Cell Lymphoma

    Amount: $109,354.00

    DESCRIPTION (provided by applicant): Mantle cell lymphoma (MCL) is a B-cell malignancy that is characterized by dysregulation of various oncogenes. Building on evidence that retinoic acid and its deri ...

    SBIRPhase I2009Department of Health and Human Services
  3. Inhalable amphotericin B nanodisk therapy for aspergillosis in HIV-infected patie

    Amount: $421,057.00

    DESCRIPTION (provided by applicant): Aspergillus fumigatus is an opportunistic pathogenic fungus that predominantly infects immunocompromised patients. It is the most common cause of infectious pneum ...

    SBIRPhase II2007Department of Health and Human Services
  4. Inhalable amphotericin B nanodisk therapy for pulmonary aspergillosis

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Aspergillus fumigatus is an opportunistic pathogenic fungus that predominantly infects immunocompromised patients. It is the most common cause of infectious pneum ...

    SBIRPhase I2005Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government